BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15621669)

  • 1. Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour.
    Reddy LH; Sharma RK; Murthy RS
    J Drug Target; 2004; 12(7):443-51. PubMed ID: 15621669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice.
    Harivardhan Reddy L; Sharma RK; Chuttani K; Mishra AK; Murthy RS
    J Control Release; 2005 Jul; 105(3):185-98. PubMed ID: 15921775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and biodistribution studies of Doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques.
    Reddy LH; Murthy RS
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Dec; 148(2):161-6. PubMed ID: 15744366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced delivery of etoposide to Dalton's lymphoma in mice through polysorbate 20 micelles.
    Reddy LH; Sharma RK; Murthy RR
    Acta Pharm; 2006 Jun; 56(2):143-55. PubMed ID: 16613722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats.
    Ambruosi A; Khalansky AS; Yamamoto H; Gelperina SE; Begley DJ; Kreuter J
    J Drug Target; 2006 Feb; 14(2):97-105. PubMed ID: 16608736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of doxorubicin-loaded poly (ε-caprolactone)-b-poly (N-vinylpyrrolidone) micelles enhances antitumor effect in lymphoma.
    Hira SK; Mishra AK; Ray B; Manna PP
    PLoS One; 2014; 9(4):e94309. PubMed ID: 24714166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies.
    Zhang X; Sun X; Li J; Zhang X; Gong T; Zhang Z
    Pharmazie; 2011 Jul; 66(7):496-505. PubMed ID: 21812324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
    Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
    Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
    Gao ZG; Lee DH; Kim DI; Bae YH
    J Drug Target; 2005 Aug; 13(7):391-7. PubMed ID: 16308207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    El-Ghareb WI; Swidan MM; Ibrahim IT; Abd El-Bary A; Tadros MI; Sakr TM
    Int J Pharm; 2020 Aug; 586():119514. PubMed ID: 32565281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor uptake, biodistribution and pharmacokinetics of etoposide loaded nanoparticles in Dalton's lymphoma tumor bearing mice.
    Snehalatha M; Kolachina V; Saha RN; Babbar AK; Sharma N; Sharma RK
    J Pharm Bioallied Sci; 2013 Oct; 5(4):290-7. PubMed ID: 24302837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect.
    Son YJ; Jang JS; Cho YW; Chung H; Park RW; Kwon IC; Kim IS; Park JY; Seo SB; Park CR; Jeong SY
    J Control Release; 2003 Aug; 91(1-2):135-45. PubMed ID: 12932645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
    J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats.
    Ambruosi A; Yamamoto H; Kreuter J
    J Drug Target; 2005 Dec; 13(10):535-42. PubMed ID: 16390814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly[lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection.
    Hsu MY; Huang YT; Weng CJ; Chen CM; Su YF; Chu SY; Tseng JH; Wu RC; Liu SJ
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110937. PubMed ID: 32155454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin.
    Liu H; Xu H; Wang Y; He Z; Li S
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1031-8. PubMed ID: 22794192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.